Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer?

PURPOSE: We aimed to determine the COVID-19 infection rate and determine the factors that affect hospitalization and prognosis in patients receiving systemic chemotherapy (CT), immunotherapy (IT) and molecular-targeted therapies at our hospital within three months after the onset of COVID-19 pandemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayhan, Murat, Laçin, Şahin, Özyükseler, Deniz T, Sürmeli, Heves, Doğan, Akif, Turan, Merve, odabas, Hatice, Turan, Nedim, Yıldırım, Mahmut Emre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107490/
https://www.ncbi.nlm.nih.gov/pubmed/33961521
http://dx.doi.org/10.1177/10781552211015762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107490/
https://www.ncbi.nlm.nih.gov/pubmed/33961521
http://dx.doi.org/10.1177/10781552211015762

Ejemplares similares